Biologic clears 40 percent of patients after a year

| Melissa Leavitt

Secukinumab, a drug in clinical trials for psoriasis, can keep patients clear for a full year, according to study results presented at the European Academy of Dermatology and Venereology meeting earlier this month.

The study analyzed data from a Phase III clinical trial for the drug. In July, results from the trial were published in the New England Journal of Medicine. These results showed that taking a 300 milligram (mg) dose of the drug for three months delivered complete skin clearance to more than a quarter of patients.

Now a new analysis of the data shows that the number of patients with clear skin kept growing throughout the year. Almost 40 percent of patients taking the 300 mg dose had complete skin clearance after a year on the drug, researchers report.

During the same amount of time, 60 percent of patients at this dose achieved a 90 percent improvement in their psoriasis, according to the data.

Approximately 20 percent of patients taking a lower dose of the drug also achieved clear skin after a year.

According to the results, approximately 5 percent of patients in both dosing groups experienced a serious side effect during the year. The most common side effects included cold, headache, and upper respiratory tract infections.

Secukinumab, manufactured by Novartis, targets interleukin-17 (IL-17), which is a protein involved in the inflammatory process of psoriasis. Food and Drug Administration (FDA) approval {} for the drug is anticipated in the coming months.

Two other drugs targeting IL-17, brodalumab and ixekizumab, are also being developed as treatments for psoriasis.

Driving discovery, creating community

For more than 50 years, we’ve been driving efforts to cure psoriatic disease and improve the lives of those affected. But there’s still plenty to do! Learn how you can help our advocacy team shape the laws and policies that affect people with psoriasis and psoriatic arthritis – in your state and across the country. Help us raise funds to support research by joining Team NPF, where you can walk, run, cycle, play bingo or create your own fundraising event. If you or someone you love needs free, personalized support for living a healthier life with psoriatic disease, contact our Patient Navigation Center. And keep the National Psoriasis Foundation going strong by making a donation today. Together, we will find a cure.

Recent Advance Posts

Doctor and patient in the exam room
What does your primary care provider have to do with managing your psoriatic...
People meeting around a table for discussion
Have we developed the tools to turn psoriasis and psoriatic arthritis into...
The Patient Navigation Center helps a woman whose PsA went undiagnosed for...
hands holding signs numbers 1 through 5
Psoriatic arthritis is a complicated disease. Learn something new today.
FDA approval stamp
Clinical trial data show drug may help you achieve clear skin.
Test tubes in a lab
A study of immune cells points to clues on how psoriasis makes a person more...
Man with joint pain
A physical therapist weighs in on the exercises and activities you can do even...
NPF volunteer at a Team NPF Cycle event
When a new doctor finally took a close look at all of Erin Faulhaber’s symptoms...
Advocates visiting Congress
Forced to retire early because of his PsA, former diplomat Stephen Keat...